Deficiency of Adenosine Deaminase 2 (DADA2): Updates on the Phenotype, Genetics, Pathogenesis, and Treatment
2018 · Journal of Clinical Immunology · 394 citations
https://doi.org/10.1007/s10875-018-0525-8
I
Ivona Aksentijevich
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
264
Papers
24.6K
Citations
73
h-index
161
i10-index
Ivona Aksentijevich is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Inflammasome and immune disorders & interferon and immune responses & Immunodeficiency and Autoimmune Disorders. The author has an h-index of 73, co-authored 225 publications.
ORCID: 0000-0002-6564-7214Papers by this author
worksA dominant autoinflammatory disease caused by non-cleavable variants of RIPK1
2019 · Nature · 260 citations
https://doi.org/10.1038/s41586-019-1830-y
Guidelines for the genetic diagnosis of hereditary recurrent fevers
2012 · Annals of the Rheumatic Diseases · 196 citations
https://doi.org/10.1136/annrheumdis-2011-201271
Treatment Strategies for Deficiency of Adenosine Deaminase 2
2019 · New England Journal of Medicine · 190 citations
https://doi.org/10.1056/nejmc1801927
Human inborn errors of immunity: 2024 update on the classification from the International Union of Immunological Societies Expert Committee
2025 · Journal of Human Immunity · 183 citations
https://doi.org/10.70962/jhi.20250003
Deficiency of adenosine deaminase 2 triggers adenosine-mediated NETosis and TNF production in patients with DADA2
2019 · Blood · 157 citations
https://doi.org/10.1182/blood.2018892752
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat